Company intelligence / Profile preview

Tawalu Pharma

Istanbul, Istanbul Province, Turkeyhupfer.com ↗

Ownership: Private
Employees: ~75
Development stage: Commercial

Overview

Tawalu Pharma is a Turkish pharmaceutical company established in 2020. It focuses on the development and manufacturing of a wide range of drug products—including solid, liquid, semi-solid, and sterile formulations—serving both domestic and international markets. The company is committed to improving health through innovative medical solutions but has not publicly disclosed specific clinical trial results or proprietary drug candidates as of mid-2025.

Modalities: Small moleculeBiologic
Industry: Biotech

Beyond the preview

Go deeper on Tawalu Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tawalu Pharma.

Explore the full profile